Skip to content

Abbott ABT Total Equity

Total Equity at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$24.13B-4.4%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$6.85B+2.6%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$84.97B+8.3%
Haemonetics logo
HaemoneticsHAE
$796.32M-3.0%
Artivion logo
ArtivionAORT
$450.47M+53.1%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$1.63B+13.9%

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$6.8B+4.1%
Total debt$34.0B+157%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$179.51B-18.3%
Enterprise value$206.76B-13.1%
P/E33.1×+17.4×
P/S3.9×-1.2×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.3%+0.6pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's total equity?
Abbott (ABT) reported total equity of $52.06B in Q1 2026.
How has Abbott's total equity changed year-over-year?
Abbott's total equity increased by 6.7% year-over-year, from $48.81B to $52.06B.
What is the long-term trend for Abbott's total equity?
Over 5 years (2020 to 2025), Abbott's total equity has grown at a 9.7% compound annual growth rate (CAGR), from $32.78B to $52.13B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.